3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
3
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Carboplatin
18
Paclitaxel
17
Bevacizumab
17
olaparib
8
Specimen Handling
7
liposomal doxorubicin
6
pembrolizumab
5
Taxes
5
Biopsy
5
cemiplimab
4
Magnetic Resonance Spectroscopy
4
sarilumab
3
niraparib
3
mirvetuximab soravtansine
3
Topotecan
3
Standard of Care
3
Letrozole
3
Gemcitabine
3
Cisplatin
3
130-nm albumin-bound paclitaxel
3
taxane
2
talazoparib
2
palbociclib
2
abemaciclib
2
Temozolomide
2
Surgical Procedures, Operative
2
Practice Guidelines as Topic
2
Poly(ADP-ribose) Polymerase Inhibitors
2
Immunoglobulin G
2
Fulvestrant
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Fallopian Tube Neoplasms
×
GEN-1
×
Clear all
NCT06915025
2026-05-04
OVATION-3
Imunon
Phase 3
Recruiting
500 enrolled